Ian Shakil, CHIEF STRATEGY OFFICER at Augmedix, Inc. (AUGX), sold 500 shares at $3.80 ($2K) on 2024-04-15, disclosed to the SEC on 2024-04-16.
Scheduled sale ($2k) by CHIEF STRATEGY OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AUGX | SELL | 2024-04-11 | $738K | — | Filing → |
| AUGX | SELL | 2024-04-09 | $678K | — | Filing → |
| AUGX | SELL | 2024-04-09 | $260K | — | Filing → |